Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metabolic Dysfunction Associated Steatohepatitis (MASH)”

99 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 99 results

Large-scale testing (Phase 3)Looking for participantsNCT06528314
What this trial is testing

A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH

Who this might be right for
NASH - Nonalcoholic SteatohepatitisMASH - Metabolic Dysfunction-Associated Steatohepatitis
Akero Therapeutics, Inc 2,150
Large-scale testing (Phase 3)Looking for participantsNCT06632457
What this trial is testing

LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis

Who this might be right for
Metabolic Dysfunction Associated Steatohepatitis
Boehringer Ingelheim 1,590
Not applicableStudy completedNCT07389122
What this trial is testing

Adherence and Tolerability of Four Very Low-Calorie Ketogenic Diet Approaches in Adults With Obesity or Complicated Overweight

Who this might be right for
Obesity & OverweightMASLD/MASH (Metabolic Dysfunction-Associated Steatotic Liver Disease / Metabolic Dysfunction-Associated Steatohepatitis)Type 2 Diabetes+1 more
University of Bologna 110
Not applicableLooking for participantsNCT07685353
What this trial is testing

Influence of Donor and Recipient Genetic Polymorphisms on Graft Steatosis After Liver Transplant

Who this might be right for
Chronic Liver Disease and Cirrhosis
Institute of Liver and Biliary Sciences, India 50
Testing effectiveness (Phase 2)Looking for participantsNCT07660848
What this trial is testing

HRS-4729 Injection and HRS9531 Injection in Participants With Metabolic Dysfunction-Associated Steatohepatitis

Who this might be right for
Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Fujian Shengdi Pharmaceutical Co., Ltd. 160
Not applicableEnrolling By InvitationNCT06986447
What this trial is testing

Assessment of Non-Invasive Testing in Major Liver-Related Outcomes

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver DiseaseMASLDMASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease+2 more
HRI-MAIL-NIT 1,689
Post-approval studies (Phase 4)Not Yet RecruitingNCT07680478
What this trial is testing

Nutrition Intervention Combined With Resmetirom for MASH

Who this might be right for
Metabolic Dysfunction-Associated Steatohepatitis (MASH)
City University of New York 120
Not applicableLooking for participantsNCT07280143
What this trial is testing

The Development of MASLD Among Survivors of Breast or Colorectal Cancer

Who this might be right for
Breast Cancer SurvivorsColorectal (Colon or Rectal) Cancer SurvivorsMASLD/MASH (Metabolic Dysfunction-Associated Steatotic Liver Disease / Metabolic Dysfunction-Associated Steatohepatitis)
University of Bern 200
Not applicableLooking for participantsNCT07476703
What this trial is testing

Expanded Studies on the SCAPIS Stockholm Reexamination Cohort

Who this might be right for
Coronary Artery DiseaseArterial Stiffness, Blood PressureAORTIC VALVE DISEASES+9 more
Danderyd Hospital 1,400
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07276204
What this trial is testing

Betaine vs. Placebo for Serologically Diagnosed Metabolic Dysfunction-associated Steatohepatitis (MASH)

Who this might be right for
MASH - Metabolic Dysfunction-Associated Steatohepatitis
Southern California Institute for Research and Education 70
Early research (Phase 1)Looking for participantsNCT07807059
What this trial is testing

A Single-Dose Pharmacokinetic Study of HRS-4729 Injection in Healthy Participants and Patients With Renal Impairment

Who this might be right for
Overweight/ObesityMetabolic Dysfunction-associated Steatotic Liver Disease/Steatohepatitis (MASLD/MASH)Type 2 Diabetes Mellitus
Fujian Shengdi Pharmaceutical Co., Ltd. 32
Early research (Phase 1)Study completedNCT05395481
What this trial is testing

A Single-Ascending and Repeated Dose Study of LY3849891 in Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

Who this might be right for
Metabolic Dysfunction-Associated Steatohepatitis (MASH)Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD)
Eli Lilly and Company 115
Not applicableNot Yet RecruitingNCT07730853
What this trial is testing

Isocaloric Navy-Bean Substitution in Adults With MASLD

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)Liver FibrosisMetabolic Dysfunction-Associated Steatohepatitis (MASH)
Icahn School of Medicine at Mount Sinai 40
Early research (Phase 1)Looking for participantsNCT07553663
What this trial is testing

Evaluating the Pharmacokinetics and Safety of Miricorilant

Who this might be right for
Nonalcoholic Steatohepatitis (NASH)Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated CirrhosisMetabolic Dysfunction-associated Steatotic Liver Disease (MASLD)+1 more
Corcept Therapeutics
Testing effectiveness (Phase 2)Looking for participantsNCT07325526
What this trial is testing

Test Whether BI 3802876 is Tolerated in People With Compensated Liver Cirrhosis Due to Metabolic Dysfunction- Associated Steatohepatitis (MASH)

Who this might be right for
Liver Cirrhosis
Boehringer Ingelheim 30
Testing effectiveness (Phase 2)Looking for participantsNCT07335601
What this trial is testing

Study to Evaluate Resmetirom in Post-Liver Transplant Patients With MASH

Who this might be right for
MASH - Metabolic Dysfunction-Associated Steatohepatitis
Madrigal Pharmaceuticals, Inc. 120
Large-scale testing (Phase 3)WithdrawnNCT06692283
What this trial is testing

Study Evaluating the Safety and Efficacy of Denifanstat in Patients With MASLD and MASH

Who this might be right for
MASLDMASHNASH+4 more
Sagimet Biosciences Inc.
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07025980
What this trial is testing

Effect of Sinbiotic With Multispecies Probiotics on Liver Parameters Liver Enzymes, Ultrasound, Elastography and Adipokines in Same Cases) in Patients With Metabolic Associated Steatotic Liver Disease.

Who this might be right for
MASLD/MASH (Metabolic Dysfunction-Associated Steatotic Liver Disease / Metabolic Dysfunction-Associated Steatohepatitis)Diabetes MellitusHypertension+1 more
Eva Cubric
Large-scale testing (Phase 3)Looking for participantsNCT07795164
What this trial is testing

Phase 3 Study of the Efficacy, Safety, and Clinical Outcomes of Pemvidutide in MASH

Who this might be right for
Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Altimmune, Inc. 1,800
Early research (Phase 1)Looking for participantsNCT05945537
What this trial is testing

INI-822 in Healthy Volunteers and Participants With Metabolic Dysfunction-Associated Steatohepatitis (MASH) or Presumed MASH

Who this might be right for
Metabolic Dysfunction-Associated Steatohepatitis
Inipharm Australia Pty Ltd 168
Next Page
15
114